Article Versions Notes

Momma T, Okayama H, Hayashishita S, Yamaguchi D, Fujii A, Katagata M, Matsumoto T, Ujiie D, Chida S, Saze Z, et al. KRAS G12A Identifies a High-Risk Subset in Resected Stage II–III Colorectal Cancer. Cancers. 2025; 17(22):3599. https://doi.org/10.3390/cancers17223599

Momma, Tomoyuki, Hirokazu Okayama, Sohei Hayashishita, Daiki Yamaguchi, Ayumi Fujii, Masanori Katagata, Takuro Matsumoto, Daisuke Ujiie, Shun Chida, Zenichiro Saze, and et al. 2025. "KRAS G12A Identifies a High-Risk Subset in Resected Stage II–III Colorectal Cancer" Cancers 17, no. 22: 3599. https://doi.org/10.3390/cancers17223599

Momma, T., Okayama, H., Hayashishita, S., Yamaguchi, D., Fujii, A., Katagata, M., Matsumoto, T., Ujiie, D., Chida, S., Saze, Z., Nakajima, S., Mimura, K., Saito, M., Sakamoto, W., & Kono, K. (2025). KRAS G12A Identifies a High-Risk Subset in Resected Stage II–III Colorectal Cancer. Cancers, 17(22), 3599. https://doi.org/10.3390/cancers17223599